AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

* This information shall be deemed to be “furnished” and not filed herewith.

AVADEL PHARMACEUTICALS PLC Exhibit
EX-99.1 2 tv488037_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1       Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results   Fourth quarter and full year revenues of $34.2 million and $172.7 million,…
To view the full exhibit click here